Mary Sontrop

Mary Sontrop

Mary has considerable experience in the biopharmaceutical sector across manufacturing operations, quality and business integration. During her 28 years with CSL Limited (CSL) she participated in CSL’s major international acquisitions being primarily responsible for the turnaround of unprofitable manufacturing operations, subsequently delivering a globally integrated manufacturing network spanning four countries. As head of CSL’s Australia and New Zealand pharmaceutical business she and her team delivered one of Australia’s most successful immunization programs; human papilloma virus and achieved FDA (US Food &Drug Administration) approval to manufacture and export CSL’s seasonal and pandemic influenza vaccines.